| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $9.0M | +7.0% |
| SG&A Expense | $8.5M | -30.7% |
| Operating Income | -$17.5M | +15.4% |
| Interest Expense | $292K | +775.1% |
| Pre-tax Income | -$17.7M | +14.6% |
| Net Income | -$17.7M | +14.6% |
| EPS (Basic) | -$1.56 | +44.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.4M | -67.5% |
| Short-term Investments | $933 | +0.0% |
| Current Assets | $7.9M | -58.3% |
| Total Assets | $11.4M | -50.2% |
| Current Liabilities | $7.0M | +496.0% |
| Total Liabilities | $7.5M | +268.3% |
| Stockholders' Equity | $3.9M | -81.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.9M | -52.2% |
| Capital Expenditures | $153K | -81.2% |
| Investing Cash Flow | -$153K | +81.3% |
| Financing Cash Flow | $4.9M | -81.5% |
| Free Cash Flow | -$16.0M | -42.6% |